Ovestin

Medicinal product

(Invented) name

Ovestin

Active substance (s)

Estriolis

Strength

500 µg

Pharmaceutical form

ovulės

Route (s) of administration

vartoti į makštį

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

G03CA04, Estriol

Marketing authorisation holder

UAB Limedika, Lietuva

Date of authorisation

2019-09-10

Date of renewal

Documents

1025_Ovestin_2024-03-04_K.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

ovulėje yra	1 vnt.
Estriolis	500 µg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
102348	88448	1088448	lizdinė plokštelė	N15		Receptinis	LT/L/19/1025/001	Tiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2019-09-10	Registruotas